Agios Pharmaceuticals, Inc

(NASDAQ:AGIO)

Latest On Agios Pharmaceuticals, Inc (AGIO):

Date/Time Type Description Signal Details
2023-05-24 13:19 ESTNewsAgios Pharmaceuticals: Good Execution, A Good Deal Of Cash, Some HurdlesN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:00 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37MN/A
2023-05-03 20:46 ESTNewsAgios Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-02-24 01:00 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call TranscriptN/A
2023-02-23 11:31 ESTNewsAgios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35MN/A
2023-02-22 09:46 ESTNewsAgios Pharma: Multiple Growth Catalysts If Pyrukynd Conversions Pull ThroughN/A
2023-01-11 19:46 ESTNewsAgios Pharmaceuticals (AGIO) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2022-12-12 09:07 ESTNewsAgios rare blood disorder drug Pyrukynd sustains benefits in patients in long term dataN/A
2022-11-17 17:06 ESTNewsAgios Pharmaceuticals upgraded to neutral at Goldman Sachs on Pyrukynd outlookN/A
2022-11-12 00:39 ESTNewsAgios granted EU approval for Pyrukynd in pyruvate kinase deficiencyN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-03 22:53 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72MN/A
2022-10-30 23:18 ESTNewsAgios Pharmaceuticals: A Big Year On The HorizonN/A
2022-10-27 21:23 ESTNewsAgios sells its rights to royalties on U.S. sales of cancer drug Tibsovo for $131.8MN/A
2022-09-19 18:38 ESTNewsAgios appoints Cecilia Jones as finance chiefN/A
2022-09-16 22:56 ESTNewsAgios Pyrukynd for rare blood disorder gets EMA panel backing for approval in EUN/A
2022-09-07 13:53 ESTNewsAgios CFO Jonathan Biller to quitN/A
2022-09-01 18:52 ESTNewsAgios adds more than 13% after Novo deal to acquire rival FormaN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:04 ESTNewsAgios stock rises as Q2 sees new drug Pyrukynd bring in revenueN/A
2022-08-04 07:32 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07N/A
2022-07-27 15:35 ESTNewsAgios gains as blood disorder therapy draws positive viewsN/A
2022-07-26 12:48 ESTNewsAgios Pharmaceuticals Is A Buy On Coming Revenue RampN/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals hires new CEON/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals appoints new board chair, CEON/A
2022-06-18 02:50 ESTNewsAgios Pharmaceuticals (AGIO) Presents At EHA 2022 Conference - SlideshowN/A
2022-05-18 02:34 ESTNewsAgios chief scientific officer to depart amid layoffs as company pivots to genetic diseasesN/A
2022-05-10 23:23 ESTNewsAgios: Approved Product, Upcoming CatalystsN/A
2022-05-10 01:38 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88MN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:11 ESTNewsAgios Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-02-25 04:07 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-25 04:06 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:21 ESTNewsAgios Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-24 08:20 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12N/A
2022-02-23 12:21 ESTNewsAgios Pharmaceuticals With FDA Approval Is A BuyN/A
2022-02-19 06:37 ESTNewsAgios Pharmaceuticals' mitapivat approved by FDA for pyruvate kinase deficiencyN/A
2022-02-19 06:36 ESTNewsAgios vindicated with FDA approval for Pyrukynd - H.C. WainwrightN/A
2022-02-18 08:40 ESTNewsAgios Pyrukynd for rare blood disorder gets US FDA approvalN/A
2022-01-20 15:39 ESTNewsAgios Before The February PDUFAN/A
2021-12-14 09:40 ESTNewsAgios presents mitapivat long-term data in PK deficiency at ASH 2021N/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Dr. Jackie Fouse on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-03 07:29 ESTNewsAgios Pharmaceuticals EPS beats by $1.46N/A
2021-11-02 11:38 ESTNewsAgios Pharmaceuticals Q3 2021 Earnings PreviewN/A

About Agios Pharmaceuticals, Inc (AGIO):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA (enasidenib), an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has completed Phase II clinical trials to treat IC eligible frontline AML; that is in Phase III clinical trials for treating IC ineligible frontline AML; and that is in Phase III clinical trials for the treatment of cholangiocarcinoma, as well as in early stage clinical development to treat glioma and solid tumors. In addition, the company is developing IDHIFA, which has completed Phase II clinical study for treating IC eligible frontline AML; and that is in Phase I/II clinical trials for the treatment of IC ineligible frontline AML. Further, it is developing mitapivat, which is in Phase III clinical trials to treat pyruvate kinase deficiency, as well as in Phase II clinical study for treating thalassemia and sickle cell disease; vorasidenib (AG-881) that is in Phase I clinical trials for the treatment of solid tumors, including glioma; AG-270, which is in Phase I dose-escalation trial to treat methylthioadenosine phosphorylase deleted tumors; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is based in Cambridge, Massachusetts.

See Advanced Chart

General

  • Name Agios Pharmaceuticals, Inc
  • Symbol AGIO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 562
  • Fiscal Year EndDecember
  • IPO Date2013-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.agios.com
View More

Valuation

  • Forward PE 8.1
  • Price/Sales (Trailing 12 Mt.) 17.51
  • Price/Book (Most Recent Quarter) 8.98
  • Enterprise Value Revenue 15.36
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.07
  • Next Year EPS Estimate -$6.10
  • Next Quarter EPS Estimate -$1.29
  • Profit Margin -161%
  • Operating Margin -156%
  • Return on Assets -23%
  • Return on Equity -63%
  • Revenue 203.2 million
  • Earnings Per Share -$6.67
  • Revenue Per Share $2.95
  • Gross Profit -167079000
  • Quarterly Earnings Growth 24.3%
View More

Highlights

  • Market Capitalization 3.38 billion
  • EBITDA -399112000
  • PE Ratio 1.63
  • Analyst Target Price $64.89
  • Book Value Per Share $5.77
View More

Share Statistics

  • Shares Outstanding 69.36 million
  • Shares Float 61.75 million
  • % Held by Insiders 1133%
  • % Held by Institutions 92.34%
  • Shares Short 5.82 million
  • Shares Short Prior Month 5.68 million
  • Short Ratio 8.4
  • Short % of Float 11%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.62
  • 52 Week High $58.93
  • 52 Week Low $32.47
  • 50 Day Moving Average 50.87
  • 200 Day Moving Average 42.95
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Agios Pharmaceuticals, Inc (AGIO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Agios Pharmaceuticals, Inc (AGIO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$44.05 million-$1.41-$1.31-7.96%
2020-09-302020-11-05$34.71 million-$1.43-$1.36-5.47%
2020-06-302020-07-30$N/A-$1.31-$1.363.72%
2020-03-312020-04-30$N/A-$0.59-$1.6463.94%
2019-12-312020-02-13$35.44 million-$1.60-$1.684.94%
2019-09-302019-10-31$26.02 million-$1.81-$1.81-0.22%
2019-06-302019-08-01$26.22 million-$1.87-$1.70-9.89%
2019-03-312019-05-02$30.23 million-$1.59-$1.759.24%
2018-12-312019-02-14$30.01 million-$1.58-$1.664.62%
2018-09-302018-11-01$15.2 million-$1.63-$1.62-0.73%
2018-06-302018-08-02$40.41 million-$1.19-$1.5523.07%
2018-03-312018-05-04$8.76 million-$1.63-$1.651.41%
2017-12-312018-02-14$9.8 million-$1.81-$1.61-12.63%
2017-09-302017-11-01$11.36 million-$1.59-$1.7810.46%
2017-06-302017-08-08$11.35 million-$1.78-$1.57-13.53%
2017-03-312017-05-04$10.51 million-$1.56-$1.8013.19%
2016-12-312017-02-16$22.65 million-$1.34-$1.5111.38%
2016-09-302016-11-03$8.99 million-$1.63-$1.51-8.2%
2016-06-302016-08-04$6.98 million-$1.47-$1.30-12.77%
2016-03-312016-05-05$31.28 million-$0.61-$0.9334.47%
2015-12-312016-02-18$6.22 million-$1.08-$0.53-102.21%
2015-09-302015-11-05$5.48 million-$1.07-$0.88-21.59%
2015-06-302015-08-06$13.22 million-$0.85-$0.46-84.78%
2015-03-312015-05-07$34.2 million-$0.13-$0.9285.87%
2014-12-312015-02-17$14.64 million-$0.76-$0.58-31.03%
2014-09-302014-11-07$33.9 million$0.10-$0.52119.23%
2014-06-302014-08-07$8.41 million-$0.54-$0.40-35%
2014-03-312014-05-08$8.41 million-$0.39-$0.37-5.41%
2013-12-312014-03-06$6.74 million-$0.40-$0.34-17.65%
2013-09-302013-11-07$6.27 million-$0.47-$0.29-62.07%
2013-06-302013-09-05$6.27 million-$2.80-$0.32-775%

Agios Pharmaceuticals, Inc (AGIO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Agios Pharmaceuticals, Inc (AGIO) Chart:

Agios Pharmaceuticals, Inc (AGIO) News:

Below you will find a list of latest news for Agios Pharmaceuticals, Inc (AGIO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Agios Pharmaceuticals, Inc (AGIO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-20150CALL0 0289.49TRUE00
2025-06-2017.50CALL0 0241.25TRUE00
2025-06-20200CALL0 0204.93TRUE00
2025-06-2022.50CALL0 0162.33TRUE00
2025-06-20250CALL0 0128.49TRUE00
2025-06-20302.5CALL0 12784.5TRUE00
2025-06-20350.55CALL0 1841.67FALSE00
2025-06-20400CALL0 276.42FALSE00
2025-06-20150PUT0 0442.55FALSE00
2025-06-2017.50PUT0 0225.7FALSE00
2025-06-20200PUT0 0186.55FALSE00
2025-06-2022.50PUT0 0151.64FALSE00
2025-06-20250.25PUT90 94107.43FALSE0.250
2025-06-20300.28PUT1 354.99FALSE0.280
2025-06-20350PUT0 053.89TRUE00
2025-06-20400PUT0 062.07TRUE00
2025-07-18150CALL0 0167.12TRUE00
2025-07-1817.50CALL0 0146.24TRUE00
2025-07-18200CALL0 0129.73TRUE00
2025-07-1822.50CALL0 095.08TRUE00
2025-07-18250CALL0 079.73TRUE00
2025-07-18300CALL0 065.93TRUE00
2025-07-18352CALL2 2555.04FALSE0.550.38
2025-07-18400CALL0 187.59FALSE00
2025-07-18150PUT0 0200.88FALSE00
2025-07-1817.50PUT0 0133.83FALSE00
2025-07-18200PUT0 0110.72FALSE00
2025-07-1822.50PUT0 090.11FALSE00
2025-07-18250PUT0 071.29FALSE00
2025-07-18301.15PUT470 059.95FALSE1.150
2025-07-18350PUT0 048.25TRUE00
2025-07-18406.5PUT2 037.17TRUE6.50
2025-08-15150CALL0 0134.07TRUE00
2025-08-1517.50CALL0 0116.67TRUE00
2025-08-15200CALL0 093.55TRUE00
2025-08-1522.50CALL0 081.95TRUE00
2025-08-15250CALL0 066.68TRUE00
2025-08-15300CALL0 30466.2TRUE00
2025-08-15352.83CALL0 60961.97FALSE00
2025-08-15401.3CALL0 4461.99FALSE00
2025-08-15450CALL0 883.86FALSE00
2025-08-15500CALL0 2077.49FALSE00
2025-08-15550CALL0 1372.18FALSE00
2025-08-15600CALL0 1181.42FALSE00
2025-08-15150PUT0 0125.28FALSE00
2025-08-1517.50PUT0 0104.57FALSE00
2025-08-15200PUT0 086.58FALSE00
2025-08-1522.50PUT0 11136.92FALSE00
2025-08-15250PUT0 1189.9FALSE00
2025-08-15300PUT0 30472FALSE00
2025-08-15350PUT0 951.72TRUE00
2025-08-15400PUT0 153.14TRUE00
2025-08-15450PUT0 053.96TRUE00
2025-08-15500PUT0 0105.53TRUE00
2025-08-15550PUT0 0119.25TRUE00
2025-08-15600PUT0 0135.57TRUE00
2025-09-19150CALL0 0103.3TRUE00
2025-09-1917.50CALL0 065.4TRUE00
2025-09-19200CALL0 085.29TRUE00
2025-09-1922.50CALL0 175.38TRUE00
2025-09-19250CALL0 071.04TRUE00
2025-09-19300CALL0 358.56TRUE00
2025-09-19350CALL0 3955.06FALSE00
2025-09-19400CALL0 1062.79FALSE00
2025-09-19450CALL0 976.81FALSE00
2025-09-19500CALL0 1377.2FALSE00
2025-09-19550CALL0 2294.94FALSE00
2025-09-19600CALL0 1111.33FALSE00
2025-09-19650CALL0 16100.21FALSE00
2025-09-19700CALL0 6127.32FALSE00
2025-09-19750CALL0 284.6FALSE00
2025-09-19800CALL0 1289.67FALSE00
2025-09-19850CALL0 194.35FALSE00
2025-09-19150PUT0 0176.7FALSE00
2025-09-1917.50PUT0 17149.96FALSE00
2025-09-19200PUT0 6131FALSE00
2025-09-1922.50PUT0 2109.38FALSE00
2025-09-19250PUT0 1184.87FALSE00
2025-09-19300PUT0 1264.88FALSE00
2025-09-19350PUT0 053.42TRUE00
2025-09-19400PUT0 053.08TRUE00
2025-09-19450PUT0 054.57TRUE00
2025-09-19500PUT0 056.24TRUE00
2025-09-19550PUT0 073.46TRUE00
2025-09-19600PUT0 0113.53TRUE00
2025-09-19650PUT0 0122.56TRUE00
2025-09-19700PUT0 0128.89TRUE00
2025-09-19750PUT0 0136.29TRUE00
2025-09-19800PUT0 0143.1TRUE00
2025-09-19850PUT0 0149.41TRUE00
2025-10-17150CALL0 0104.77TRUE00
2025-10-1717.50CALL0 090.23TRUE00
2025-10-17200CALL0 083.36TRUE00
2025-10-1722.50CALL0 075.47TRUE00
2025-10-17250CALL0 071.81TRUE00
2025-10-17300CALL0 2163.38TRUE00
2025-10-17350CALL0 31057.35FALSE00
2025-10-17402.1CALL0 558.29FALSE00
2025-10-17451.25CALL0 667.93FALSE00
2025-10-17500CALL0 1677.42FALSE00
2025-10-17550CALL0 159.9FALSE00
2025-10-17600CALL0 558.67FALSE00
2025-10-17650CALL0 567.96FALSE00
2025-10-17700CALL0 070.08FALSE00
2025-10-17750CALL0 575FALSE00
2025-10-17800CALL0 1179.52FALSE00
2025-10-17850CALL0 583.68FALSE00
2025-10-17150PUT0 4116.95FALSE00
2025-10-1717.50.9PUT0 8136.44FALSE00
2025-10-17200PUT0 7114.7FALSE00
2025-10-1722.50PUT0 287.38FALSE00
2025-10-17250PUT0 083.21FALSE00
2025-10-17300PUT0 059.65FALSE00
2025-10-17350PUT0 30054.7TRUE00
2025-10-17400PUT0 054.88TRUE00
2025-10-17450PUT0 055.01TRUE00
2025-10-17500PUT0 053.06TRUE00
2025-10-17550PUT0 052.18TRUE00
2025-10-17600PUT0 099.56TRUE00
2025-10-17650PUT0 0109.28TRUE00
2025-10-17700PUT0 0116.65TRUE00
2025-10-17750PUT0 0123.37TRUE00
2025-10-17800PUT0 0129.55TRUE00
2025-10-17850PUT0 0135.25TRUE00
2025-11-21150CALL0 0102.66TRUE00
2025-11-2117.50CALL0 086.46TRUE00
2025-11-21200CALL0 083.69TRUE00
2025-11-2122.50CALL0 066.76TRUE00
2025-11-21250CALL0 067.79TRUE00
2025-11-21300CALL0 060.61TRUE00
2025-11-21350CALL0 1361.21FALSE00
2025-11-21400CALL0 760.39FALSE00
2025-11-21450CALL0 564.26FALSE00
2025-11-21150PUT0 2140.89FALSE00
2025-11-2117.50PUT0 4101.3FALSE00
2025-11-21200PUT0 298.51FALSE00
2025-11-2122.50PUT0 087.55FALSE00
2025-11-21250PUT0 067.28FALSE00
2025-11-21300PUT0 059.06FALSE00
2025-11-21350PUT0 053.06TRUE00
2025-11-21400PUT0 054.51TRUE00
2025-11-21450PUT0 054.49TRUE00
2025-12-19150CALL0 092.31TRUE00
2025-12-1917.50CALL0 487.24TRUE00
2025-12-19200CALL0 084.06TRUE00
2025-12-1922.50CALL0 075.77TRUE00
2025-12-19250CALL0 574.14TRUE00
2025-12-19300CALL0 4270.21TRUE00
2025-12-19355.94CALL0 12265.61FALSE00
2025-12-19404.16CALL0 9064.32FALSE00
2025-12-19453CALL0 10562.53FALSE00
2025-12-19502CALL0 132662.94FALSE00
2025-12-19550CALL0 11263.52FALSE00
2025-12-19601.15CALL0 34365.8FALSE00
2025-12-19650.95CALL0 3073.16FALSE00
2025-12-19700CALL0 14077.99FALSE00
2025-12-19750.5CALL0 1583.12FALSE00
2025-12-19800.96CALL0 368.21FALSE00
2025-12-19850CALL0 068.62FALSE00
2025-12-19900CALL0 3103.13FALSE00
2025-12-19150PUT0 1136.97FALSE00
2025-12-1917.50PUT0 20286.56FALSE00
2025-12-19200PUT0 096.32FALSE00
2025-12-1922.51.7PUT1 071.91FALSE1.70
2025-12-19250PUT0 7270.9FALSE00
2025-12-19305.2PUT0 133364.08FALSE00
2025-12-19355.9PUT0 94757.31TRUE00
2025-12-19400PUT0 759.46TRUE00
2025-12-19450PUT0 159.53TRUE00
2025-12-19500PUT0 154.94TRUE00
2025-12-19550PUT0 059.02TRUE00
2025-12-19600PUT0 172.15TRUE00
2025-12-19650PUT0 067.13TRUE00
2025-12-19700PUT0 0101.88TRUE00
2025-12-19750PUT0 0107.66TRUE00
2025-12-19800PUT0 0112.99TRUE00
2025-12-19850PUT0 0116.6TRUE00
2025-12-19900PUT0 0118.47TRUE00

Latest AGIO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST11$17.4
Jun 13, 2022 7:59 PM EST189$17.4
Jun 13, 2022 7:59 PM EST128$17.4
Jun 13, 2022 7:59 PM EST200$17.38
Jun 13, 2022 7:59 PM EST17$17.4

Agios Pharmaceuticals, Inc (AGIO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000021545719003331/0000215457-19-003331-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506619000835/0000315066-19-000835-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620000791/0000315066-20-000791-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620001684/0000315066-20-001684-index.htm
2019-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423719000203/0000834237-19-000203-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423720008047/0000834237-20-008047-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221919000091/0000902219-19-000091-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221920000008/0000902219-20-000008-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119002231/0000932471-19-002231-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119004832/0000932471-19-004832-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-11-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064173/0001104659-19-064173-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920017624/0001104659-20-017624-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920018297/0001104659-20-018297-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518314801/0001193125-18-314801-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518328948/0001193125-18-328948-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518341083/0001193125-18-341083-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518353307/0001193125-18-353307-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519003167/0001193125-19-003167-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519018824/0001193125-19-018824-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039198/0001193125-19-039198-index.htm
2019-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039513/0001193125-19-039513-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519051918/0001193125-19-051918-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519107805/0001193125-19-107805-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110870/0001193125-19-110870-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110887/0001193125-19-110887-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519133821/0001193125-19-133821-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519134882/0001193125-19-134882-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519148009/0001193125-19-148009-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519162771/0001193125-19-162771-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519164072/0001193125-19-164072-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519166109/0001193125-19-166109-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519209747/0001193125-19-209747-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519237824/0001193125-19-237824-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519258364/0001193125-19-258364-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519275491/0001193125-19-275491-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519279631/0001193125-19-279631-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519283514/0001193125-19-283514-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519285887/0001193125-19-285887-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519288482/0001193125-19-288482-index.htm
2019-11-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519288495/0001193125-19-288495-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519298670/0001193125-19-298670-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519309199/0001193125-19-309199-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520005857/0001193125-20-005857-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520006338/0001193125-20-006338-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520034263/0001193125-20-034263-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520037796/0001193125-20-037796-index.htm
2020-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520041964/0001193125-20-041964-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109284/0001193125-20-109284-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109288/0001193125-20-109288-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520127627/0001193125-20-127627-index.htm
2020-04-30POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128793/0001193125-20-128793-index.htm
2020-04-30S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128809/0001193125-20-128809-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155665/0001193125-20-155665-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155682/0001193125-20-155682-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520203351/0001193125-20-203351-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520240994/0001193125-20-240994-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520249634/0001193125-20-249634-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520286235/0001193125-20-286235-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057372/0001209191-18-057372-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118059146/0001209191-18-059146-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/0001209191-19-007343-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013509/0001209191-19-013509-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013515/0001209191-19-013515-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013525/0001209191-19-013525-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013531/0001209191-19-013531-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013536/0001209191-19-013536-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119025785/0001209191-19-025785-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922218000018/0001439222-18-000018-index.htm
2019-02-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000004/0001439222-19-000004-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000009/0001439222-19-000009-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000011/0001439222-19-000011-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000017/0001439222-19-000017-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000021/0001439222-19-000021-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2019-12-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000027/0001439222-19-000027-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000028/0001439222-19-000028-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000002/0001439222-20-000002-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/0001439222-20-000003-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2020-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000014/0001439222-20-000014-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/0001439222-20-000017-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000026/0001439222-20-000026-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000039/0001439222-20-000039-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000055/0001439222-20-000055-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000059/0001439222-20-000059-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000063/0001439222-20-000063-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000069/0001439222-20-000069-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223019000005/0001562230-19-000005-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223020000005/0001562230-20-000005-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003422/9999999997-19-003422-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003444/9999999997-19-003444-index.htm
2019-07-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719006154/9999999997-19-006154-index.htm

Agios Pharmaceuticals, Inc (AGIO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc (AGIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1133%
Institutional Ownership: 9234%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-28Carman AlensonPrincipal Accounting OfficerSell152.0076.4511,620.400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2020-02-16David P SchenkeinDirectorBuy8,125.00105,692.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-22David P SchenkeinDirectorBuy2,775.00105,933.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-04-13Christopher BowdenChief Medical OfficerBuy5,280.0010,598.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerSell5,000.0066.01330,050.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerSell5,000.0068.00340,000.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell5,854.0066.03386,539.6211,384.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-05-20Christopher BowdenChief Medical OfficerBuy3,583.0035.16125,978.2811,889.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2019-02-16Steven L. HoerterChief Commercial OfficerBuy2,750.0011,981.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-16Andrew HirschChief Financial OfficerBuy2,750.0013,195.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-05-31IAN T CLARKDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-31JACQUALYN A FOUSEChief Executive OfficerBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-31Maykin HoDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-31Paul J ClancyDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-01-20Andrew HirschChief Financial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-01-20Steven L. HoerterChief Commercial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2020-02-16Andrew HirschChief Financial OfficerBuy2,750.0015,127.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-04Christopher BowdenChief Medical OfficerBuy8,526.0035.16299,774.1615,841.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell14,191.0050.03709,962.961,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell35,447.0050.101,776,025.851,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-11Christopher BowdenChief Medical OfficerSell621.0050.0231,063.231,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-13Christopher BowdenChief Medical OfficerSell7,100.0050.16356,111.861,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-03-15Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-02-22Andrew HirschChief Financial OfficerBuy3,333.0017,574.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2019-11-12CORP /DE/ CELGENE10% Share HolderBuy403,225.0031.0012,499,975.001,777,824.00https://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-12-26Carman AlensonPrincipal Accounting OfficerSell2,950.0050.09147,765.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-02-20Carman AlensonPrincipal Accounting OfficerSell2,427.0053.37129,528.99184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-26Carman AlensonPrincipal Accounting OfficerSell472.0047.1222,240.64184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-03-02Carman AlensonPrincipal Accounting OfficerSell345.0047.3016,318.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-09-02Carman AlensonPrincipal Accounting OfficerSell250.0039.939,982.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2019-05-31David ScaddenDirectorBuy1,400.001,971.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2020-04-13Andrew HirschChief Financial OfficerBuy5,387.0021,905.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2018-09-12JOHN MARAGANOREDirectorSell14,162.0071.741,015,981.8822,047.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-11Christopher BowdenChief Medical OfficerBuy621.0035.1621,834.362,271.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2018-12-21Scott BillerChief Scientific OfficerBuy20,500.002.3447,918.7524,637.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2020-04-22Andrew HirschChief Financial OfficerBuy5,893.0026,199.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2019-02-27Scott BillerChief Scientific OfficerSell9,000.0065.00585,000.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0068.2213,644.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell599.0068.1240,803.8826,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell2,600.0067.73176,098.0026,711.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy428.0031.6413,541.9226,939.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell2,401.0067.61162,331.6127,110.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-02-16Scott BillerChief Scientific OfficerBuy2,750.0027,387.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy1,766.000.47830.0228,277.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0066.4513,290.0029,311.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy2,572.0039.76102,262.7229,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerBuy3,000.0039.76119,280.0029,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2020-05-29JOHN MARAGANOREDirectorBuy1,878.0030,172.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy4,154.009.0537,593.7032,431.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2020-05-29IAN T CLARKDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-05-29Maykin HoDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-05-29Paul J ClancyDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2019-06-11Scott BillerChief Scientific OfficerBuy7,218.002.3416,872.0833,729.00https://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy3,080.0031.6497,451.2035,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-05-31Kaye I Foster-CheekDirectorBuy1,400.003,600.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2018-09-11JOHN MARAGANOREDirectorSell2,400.0073.82177,168.0036,209.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-05Christopher BowdenChief Medical OfficerBuy35,447.0035.161,246,316.5237,097.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-05-31JOHN MARAGANOREDirectorBuy1,400.0037,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy2,800.003,774.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-02-21Carman AlensonPrincipal Accounting OfficerBuy3,300.003,812.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2020-05-29David ScaddenDirectorBuy1,878.003,849.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2018-09-11JOHN MARAGANOREDirectorSell11,155.0072.52808,960.6038,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2019-11-13JACQUALYN A FOUSEChief Executive OfficerBuy40,322.0031.001,249,982.0041,722.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2020-02-16Christopher BowdenChief Medical OfficerBuy2,750.004,400.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell21.0071.771,507.1750,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell100.0071.427,142.0050,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell1,100.0071.0578,155.0050,953.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell700.0070.2349,161.0051,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell2,200.0069.44152,768.0051,732.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell979.0069.4768,011.1352,053.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell900.0068.5661,704.0053,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2020-04-13JACQUALYN A FOUSEChief Executive OfficerBuy12,379.0054,101.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-05-29Kaye I Foster-CheekDirectorBuy1,878.005,478.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-04-13Bruce CarChief Scientific OfficerBuy6,874.006,874.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-02-22Christopher BowdenChief Medical OfficerBuy3,333.006,914.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2019-01-20Christopher BowdenChief Medical OfficerBuy6,265.007,189.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell1,300.0064.6484,032.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell100.0068.726,872.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy72,619.002.34169,928.4672,619.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell1,500.0068.09102,135.007,338.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy2,500.0031.6479,100.0075,119.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00790.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-16Christopher BowdenChief Medical OfficerBuy2,750.008,013.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2020-05-20Christopher BowdenChief Medical OfficerSell3,583.0050.01179,200.168,306.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2018-09-10David P SchenkeinChief Executive OfficerBuy8,730.0031.64276,217.2083,849.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2020-04-13Jonathan BillerChief Legal OfficerBuy8,523.008,523.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell8,700.0064.09557,583.008,538.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2020-02-22Carman AlensonPrincipal Accounting OfficerBuy691.00875.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-13Christopher BowdenChief Medical OfficerBuy7,100.0035.16249,636.008,750.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell2,546.0066.85170,200.108,838.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-02-16David P SchenkeinDirectorBuy8,125.0091,974.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00974.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-11-13David P SchenkeinDirectorBuy8,064.0031.00249,984.0097,567.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm